235 related articles for article (PubMed ID: 28923860)
1.
Kather JN; Poleszczuk J; Suarez-Carmona M; Krisam J; Charoentong P; Valous NA; Weis CA; Tavernar L; Leiss F; Herpel E; Klupp F; Ulrich A; Schneider M; Marx A; Jäger D; Halama N
Cancer Res; 2017 Nov; 77(22):6442-6452. PubMed ID: 28923860
[TBL] [Abstract][Full Text] [Related]
2. Determinants of metastatic competency in colorectal cancer.
Tauriello DV; Calon A; Lonardo E; Batlle E
Mol Oncol; 2017 Jan; 11(1):97-119. PubMed ID: 28085225
[TBL] [Abstract][Full Text] [Related]
3. Novel avenues in immunotherapies for colorectal cancer.
Pardieck IN; Jawahier PA; Swets M; van de Velde CJ; Kuppen PJ
Expert Rev Gastroenterol Hepatol; 2016; 10(4):465-80. PubMed ID: 26582071
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Screening of Combinatorial Immunotherapies with Patient-Specific
Kather JN; Charoentong P; Suarez-Carmona M; Herpel E; Klupp F; Ulrich A; Schneider M; Zoernig I; Luedde T; Jaeger D; Poleszczuk J; Halama N
Cancer Res; 2018 Sep; 78(17):5155-5163. PubMed ID: 29967263
[TBL] [Abstract][Full Text] [Related]
5. Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy.
Becht E; de Reyniès A; Giraldo NA; Pilati C; Buttard B; Lacroix L; Selves J; Sautès-Fridman C; Laurent-Puig P; Fridman WH
Clin Cancer Res; 2016 Aug; 22(16):4057-66. PubMed ID: 26994146
[TBL] [Abstract][Full Text] [Related]
6. Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.
Roelands J; Kuppen PJK; Vermeulen L; Maccalli C; Decock J; Wang E; Marincola FM; Bedognetti D; Hendrickx W
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064420
[TBL] [Abstract][Full Text] [Related]
7. Growth suppression of colorectal cancer by plant-derived multiple mAb CO17-1A × BR55 via inhibition of ERK1/2 phosphorylation.
Kwak DH; Moussavou G; Lee JH; Heo SY; Ko K; Hwang KA; Jekal SJ; Choo YK
Int J Mol Sci; 2014 Nov; 15(11):21105-19. PubMed ID: 25405740
[TBL] [Abstract][Full Text] [Related]
8. The potential role of immunotherapy to treat colorectal cancer.
Amin M; Lockhart AC
Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
[TBL] [Abstract][Full Text] [Related]
9. [Predictive markers of immunotherapy of colorectal cancer].
Bogner B
Magy Onkol; 2019 Sep; 63(3):192-195. PubMed ID: 31533138
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer.
Zhen YH; Liu XH; Yang Y; Li B; Tang JL; Zeng QX; Hu J; Zeng XN; Zhang L; Wang ZJ; Li XY; Ge HX; Winqvist O; Hu PS; Xiu J
Cancer Immunol Immunother; 2015 Sep; 64(9):1083-93. PubMed ID: 25990075
[TBL] [Abstract][Full Text] [Related]
11. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis.
Zhang Y; Davis C; Shah S; Hughes D; Ryan JC; Altomare D; Peña MM
Mol Carcinog; 2017 Jan; 56(1):272-287. PubMed ID: 27120577
[TBL] [Abstract][Full Text] [Related]
12. [Immunotherapy in radical surgery of colorectal carcinoma].
Brivio F; Fumagalli L; Chiarelli M; Denova M; Bertolini A; Cetta M; Nespoli A
Chir Ital; 2007; 59(5):635-40. PubMed ID: 18019635
[TBL] [Abstract][Full Text] [Related]
13. Pre-operative interleukin-2 immunotherapy induces eosinophilic infiltration in colorectal neoplastic stroma.
Bovo G; Brivio F; Brenna A; Fumagalli L; Perego P; Brivio O; Uggeri F; Lavorato F; Bratina G
Pathologica; 1995 Apr; 87(2):135-8. PubMed ID: 8532404
[TBL] [Abstract][Full Text] [Related]
14. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Kamal Y; Schmit SL; Frost HR; Amos CI
Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
[TBL] [Abstract][Full Text] [Related]
15. The evolving role of immune oncology in colorectal cancer.
Dawood S
Chin Clin Oncol; 2018 Apr; 7(2):17. PubMed ID: 29764162
[TBL] [Abstract][Full Text] [Related]
16. Host response to colorectal cancer.
Salama P; Platell C
ANZ J Surg; 2008 Sep; 78(9):745-53. PubMed ID: 18844901
[TBL] [Abstract][Full Text] [Related]
17. Immune signatures of murine and human cancers reveal unique mechanisms of tumor escape and new targets for cancer immunotherapy.
Sadun RE; Sachsman SM; Chen X; Christenson KW; Morris WZ; Hu P; Epstein AL
Clin Cancer Res; 2007 Jul; 13(13):4016-25. PubMed ID: 17606736
[TBL] [Abstract][Full Text] [Related]
18. Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.
Brivio F; Fumagalli L; Lissoni P; Nardone A; Nespoli L; Fattori L; Denova M; Chiarelli M; Nespoli A
Anticancer Res; 2006; 26(1B):599-603. PubMed ID: 16739327
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
Maccalli C; Parmiani G; Ferrone S
Immunol Invest; 2017 Apr; 46(3):221-238. PubMed ID: 28287848
[TBL] [Abstract][Full Text] [Related]
20. Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress.
Bahrami A; Khazaei M; Hassanian SM; ShahidSales S; Joudi-Mashhad M; Maftouh M; Jazayeri MH; Parizade MR; Ferns GA; Avan A
J Cell Physiol; 2018 Apr; 233(4):2928-2936. PubMed ID: 28574572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
